West Nile virus in Italy: a further threat to blood safety, a further challenge to the blood system [0.03%]
意大利的西尼罗病毒：对血液安全的进一步威胁以及对血站的进一步挑战
Giuliano Grazzini,Giancarlo Maria Liumbruno,Simonetta Pupella et al.
Giuliano Grazzini et al.
Roberto Reverberi
Roberto Reverberi
Background: Red cell alloantibodies may disappear over time and cause a delayed haemolytic reaction if their past existence is not known before a transfusion. Only few quantitative data have already been presented on this...
Peripheral blood CD5-positive B lymphocytes (B-1a cells) after allogeneic stem cell transplantation for acute myeloid leukaemia in humans [0.03%]
人类异基因造血干细胞移植后急性髓系白血病外周血CD5阳性B淋巴细胞(B-1a细胞)的研究
Dino Veneri,Massimo Franchini,Donata de Sabata et al.
Dino Veneri et al.
Background: Only few data are available in literature regarding the reconstitution of B- 1a cells after allogeneic bone marrow transplantation performed for haematological malignancies. ...
Comparative Study
Blood transfusion = Trasfusione del sangue. 2008 Oct;6(4):220-4. DOI:10.2450/2008.0010-08 2008
Audit of the clinical use of fresh-frozen plasma in Umbria: study design and results of the pilot phase [0.03%]
翁布里亚新鲜冰冻血浆临床应用审计：研究设计及试点阶段结果分析
Alfonso Iorio,Michela Basileo,Emanuela Marchesini et al.
Alfonso Iorio et al.
Background: Fresh-frozen plasma (FFP) is unanimously recognised by international guidelines as the blood component of choice for the management of acute haemorrhage when accompanied by disorders of haemostasis, for dissem...
The Chikungunya epidemic in Italy and its repercussion on the blood system [0.03%]
意大利奇昆贡亚病毒流行及其对血液系统的影响
Giancarlo Maria Liumbruno,Deanna Calteri,Kyriakoula Petropulacos et al.
Giancarlo Maria Liumbruno et al.
Background: The Chikungunya virus (CHIKV) is transmitted by Aedes mosquitoes and recently caused a massive epidemic on La Réunion Island, in the Indian Ocean. Between July and September 2007 it caused the first autochtho...
New drugs in the treatment of myelodysplastic syndromes: are they changing the role of transfusion support? [0.03%]
新型药物在骨髓增生异常综合征治疗中的应用：它们是否改变了输血支持的作用？
Alberto Grossi,Giancarlo Maria Liumbruno
Alberto Grossi
Clinical appropriateness of blood component transfusion: regulatory requirements and standards set by the Scientific Society in Italy [0.03%]
意大利血液成分输血的临床适宜性：科学协会制定的规定和标准
Giuliano Grazzini
Giuliano Grazzini
Regulatory requirements and standards on clinical appropriateness of blood component transfusion [0.03%]
有关血液成分输血临床适用性的法规要求及标准制定的思考
Paul Strengers
Paul Strengers
Willy A Flegel
Willy A Flegel
Alice Maniatis
Alice Maniatis